A call for proposals has been issued in India covering T cell based vaccines and biologics aimed at infectious diseases, cancer and autoimmune diseases, according to fundsforNGOs. The funding opportunity notice was published by the outlet on Friday, 11 September 2026. The announcement is directed at organizations working in these three disease areas.
According to fundsforNGOs, the call spans infectious diseases, cancer and autoimmune diseases as its target fields. The notice centers on two related categories of intervention — T cell based vaccines and biologics — rather than a single therapy type. No further details on eligibility, award amounts or deadlines were included in the material available from the outlet.
The three areas named in the call represent distinct challenges for immune-based treatment. Infectious diseases involve responses to external pathogens, cancer involves recognizing and targeting abnormal cells, and autoimmune diseases involve immune activity directed against the body's own tissues. Grouping them under one proposal call, as fundsforNGOs reports, places the emphasis on T cell approaches across a broad range of conditions.
Because the source material provides only the headline and summary, specifics such as who may apply, how much funding is available and when proposals are due remain unconfirmed. Applicants and observers should watch for the full call documentation from the issuing body, which would clarify eligibility criteria, submission requirements and the closing date.
